258 related articles for article (PubMed ID: 11147505)
1. The evolution and origin of motor complications in Parkinson's disease.
Obeso JA; Rodriguez-Oroz MC; Chana P; Lera G; Rodriguez M; Olanow CW
Neurology; 2000; 55(11 Suppl 4):S13-20; discussion S21-3. PubMed ID: 11147505
[TBL] [Abstract][Full Text] [Related]
2. Recognition and treatment of response fluctuations in Parkinson's disease: review article.
Verhagen Metman L
Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Parkinson's disease: levodopa as the first choice.
Katzenschlager R; Lees AJ
J Neurol; 2002 Sep; 249 Suppl 2():II19-24. PubMed ID: 12375059
[TBL] [Abstract][Full Text] [Related]
4. Complications and limitations of drug therapy for Parkinson's disease.
Jankovic J
Neurology; 2000; 55(12 Suppl 6):S2-6. PubMed ID: 11188970
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic and pharmacodynamic considerations in management of motor response fluctuations in Parkinson's disease.
Cedarbaum JM
Neurol Clin; 1990 Feb; 8(1):31-49. PubMed ID: 2181267
[TBL] [Abstract][Full Text] [Related]
6. [Motor complications in patients with Parkinson disease treated with levodopa].
Luquin MR; Obeso JA; Martínez-Lage JM
Neurologia; 1989; 4(1):4-11. PubMed ID: 2631806
[TBL] [Abstract][Full Text] [Related]
7. Motor response to levodopa and the evolution of motor fluctuations in the first decade of treatment of Parkinson's disease.
McColl CD; Reardon KA; Shiff M; Kempster PA
Mov Disord; 2002 Nov; 17(6):1227-34. PubMed ID: 12465061
[TBL] [Abstract][Full Text] [Related]
8. Levodopa induced motor complications in Thai Parkinson's disease patients.
Kulkantrakorn K; Tiamkao S; Pongchaiyakul C; Pulkes T
J Med Assoc Thai; 2006 May; 89(5):632-7. PubMed ID: 16756048
[TBL] [Abstract][Full Text] [Related]
9. Motor complications of Parkinson's disease.
Martignoni E; Riboldazzi G; Calandrella D; Riva N
Neurol Sci; 2003 May; 24 Suppl 1():S27-9. PubMed ID: 12774208
[TBL] [Abstract][Full Text] [Related]
10. Problems with current pharmacologic treatment of Parkinson's disease.
Hurtig HI
Exp Neurol; 1997 Mar; 144(1):10-6. PubMed ID: 9126144
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of dyskinesias in Parkinson's disease.
Mouradian MM; Heuser IJ; Baronti F; Fabbrini G; Juncos JL; Chase TN
Ann Neurol; 1989 May; 25(5):523-6. PubMed ID: 2774496
[TBL] [Abstract][Full Text] [Related]
12. Motor fluctuations in Parkinson's disease: central pathophysiological mechanisms, Part II.
Mouradian MM; Juncos JL; Fabbrini G; Schlegel J; Bartko JJ; Chase TN
Ann Neurol; 1988 Sep; 24(3):372-8. PubMed ID: 3228271
[TBL] [Abstract][Full Text] [Related]
13. Parkinson's disease--opportunities for novel therapeutics to reduce the problems of levodopa therapy.
Fox SH; Chuang R; Brotchie JM
Prog Brain Res; 2008; 172():479-94. PubMed ID: 18772047
[TBL] [Abstract][Full Text] [Related]
14. Presynaptic mechanisms of motor fluctuations in Parkinson's disease: a probabilistic model.
de la Fuente-Fernández R; Schulzer M; Mak E; Calne DB; Stoessl AJ
Brain; 2004 Apr; 127(Pt 4):888-99. PubMed ID: 14960500
[TBL] [Abstract][Full Text] [Related]
15. A hospital-based study: risk factors in development of motor complications in 555 Parkinson's patients on levodopa therapy.
Benbir G; Ozekmekçi S; Apaydin H; Delil S; Erginöz E
Clin Neurol Neurosurg; 2006 Dec; 108(8):726-32. PubMed ID: 16564615
[TBL] [Abstract][Full Text] [Related]
16. [Rasagiline in daily clinical use. Results of a treatment study of Parkinson patients with a combination treatment].
Jost WH; Klasser M; Reichmann H
Fortschr Neurol Psychiatr; 2008 Oct; 76(10):594-9. PubMed ID: 18833504
[TBL] [Abstract][Full Text] [Related]
17. Management for motor and non-motor complications in late Parkinson's disease.
Chan DK; Cordato DJ; O'Rourke F
Geriatrics; 2008 May; 63(5):22-7. PubMed ID: 18447408
[TBL] [Abstract][Full Text] [Related]
18. Risk factors in development of motor complications in Chinese patients with idiopathic Parkinson's disease.
Kum WF; Gao J; Durairajan SS; Man SC; Xie LX; Lu JH; Fong WL; Li M
J Clin Neurosci; 2009 Aug; 16(8):1034-7. PubMed ID: 19428256
[TBL] [Abstract][Full Text] [Related]
19. Levodopa/dopamine replacement strategies in Parkinson's disease--future directions.
Olanow CW
Mov Disord; 2008; 23 Suppl 3():S613-22. PubMed ID: 18781663
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the response to levodopa during the first 4 years of therapy.
Nutt JG; Carter JH; Lea ES; Sexton GJ
Ann Neurol; 2002 Jun; 51(6):686-93. PubMed ID: 12112073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]